TY - JOUR
T1 - Thoracic duct-cutaneous fistula in a patient with cirrhosis of the liver
T2 - successful treatment with a transjugular intrahepatic portosystemic shunt
AU - Rosser, Barry G.
AU - Poterucha, John J.
AU - McKusick, Michael A.
AU - Kamath, Patrick S.
PY - 1996
Y1 - 1996
N2 - Patients with cirrhosis of the liver have increased hepatic and gastrointestinal lymph flow that may contribute to the formation of ascites and pleural effusions. Increased lymph flow, which is due to postsinusoidal portal hypertension, causes a high rate of flow through the thoracic duct. Because of the high flow rates, disrupted lymphatic vessels in patients with cirrhosis of the liver may fail to close, a situation that results in chylous ascites, pleural effusions, or chylous fistulas. Chylous fistulas deplete proteins, fluid, and lymphocytes and thus lead to volume depletion and coagulopathy. Herein we describe an un-usual case in which a high-output traumatic thoracic duct-cutaneous fistula developed in a patient with cirrhosis and led to volume depletion and coagulopathy. Correction of the portal hypertension with placement of a transjugular intrahepatic portosystemic shunt led to closure of the fistula and normalization of accompanying metabolic abnormalities.
AB - Patients with cirrhosis of the liver have increased hepatic and gastrointestinal lymph flow that may contribute to the formation of ascites and pleural effusions. Increased lymph flow, which is due to postsinusoidal portal hypertension, causes a high rate of flow through the thoracic duct. Because of the high flow rates, disrupted lymphatic vessels in patients with cirrhosis of the liver may fail to close, a situation that results in chylous ascites, pleural effusions, or chylous fistulas. Chylous fistulas deplete proteins, fluid, and lymphocytes and thus lead to volume depletion and coagulopathy. Herein we describe an un-usual case in which a high-output traumatic thoracic duct-cutaneous fistula developed in a patient with cirrhosis and led to volume depletion and coagulopathy. Correction of the portal hypertension with placement of a transjugular intrahepatic portosystemic shunt led to closure of the fistula and normalization of accompanying metabolic abnormalities.
UR - http://www.scopus.com/inward/record.url?scp=0030317266&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030317266&partnerID=8YFLogxK
U2 - 10.1016/s0025-6196(11)64845-3
DO - 10.1016/s0025-6196(11)64845-3
M3 - Article
C2 - 8691901
AN - SCOPUS:0030317266
SN - 0025-6196
VL - 71
SP - 793
EP - 796
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 8
ER -